Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Anne Zanchi"'
Autor:
Christophe Kosinski, Georgios E. Papadakis, Olivier Salamin, Tiia Kuuranne, Raul Nicoli, Nelly Pitteloud, Anne Zanchi
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-4 (2024)
Abstract Sodium-glucose cotransporter (SGLT) 2 inhibition is a well-known target for the treatment of type 2 diabetes, renal disease and chronic heart failure. The protein SGLT2 is encoded by SLC5A2 (Solute Carrier Family 5 Member 2), which is highly
Externí odkaz:
https://doaj.org/article/0def08d6c3764469af12a82887425dff
Autor:
Valérie M. Schwitzgebel, Jean-Louis Blouin, Barbara Dehos, Bettina Köhler-Ballan, Jardena J. Puder, Claudine Rieubland, Maria Triantafyllidou, Anne Zanchi, Marc Abramowicz, Thierry Nouspikel
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundMutations in the GCK gene cause Maturity Onset Diabetes of the Young (GCK-MODY) by impairing glucose-sensing in pancreatic beta cells. During pregnancy, managing this type of diabetes varies based on fetal genotype. Fetuses carrying a GCK m
Externí odkaz:
https://doaj.org/article/e4add68890ec4c8bb0e802631da0d9d9
Autor:
Carole Bandiera, Jennifer Dotta-Celio, Isabella Locatelli, Dina Nobre, Grégoire Wuerzner, Menno Pruijm, Faiza Lamine, Michel Burnier, Anne Zanchi, Marie Paule Schneider
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Background: For every 100 patients with diabetes, 40 will develop diabetic kidney disease (DKD) over time. This diabetes complication may be partly due to poor adherence to their prescribed medications. In this study, we aimed to evaluate the differe
Externí odkaz:
https://doaj.org/article/768173c8c98b475bb70b82d0a16087d2
Autor:
Carole Bandiera, Liliane Lam, Isabella Locatelli, Jennifer Dotta-Celio, Dina Duarte, Gregoire Wuerzner, Menno Pruijm, Anne Zanchi, Marie P. Schneider
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 14, Iss 1, Pp 1-16 (2022)
Abstract Background An interprofessional medication adherence intervention led by pharmacists, combining motivational interviews and feedback with electronic monitor (EM) drug assessment, was offered to all consecutive patients with diabetic kidney d
Externí odkaz:
https://doaj.org/article/b053d490bc684fa883910acd3ce06103
Autor:
Luca Truscello, Dina Nobre, Vehashini Sabaratnam, Olivier Bonny, Grégoire Wuerzner, Michel Burnier, Fadi Fakhouri, Menno Pruijm, Anne Zanchi
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
ObjectiveIn patients with type 2 diabetes and diabetic kidney disease (DKD), explore the relationship between estimated glomerular filtration rate decline (eGFR-d) and simultaneously assessed vascular risk markers including office, ambulatory or cent
Externí odkaz:
https://doaj.org/article/525c42d33f9a4fef8eb0823a2faf72fa
Publikováno v:
Kidney and Dialysis, Vol 2, Iss 3, Pp 459-473 (2022)
Patients with type 2 diabetes (T2D) and end-stage kidney disease (ESKD) on renal replacement therapy represent a specific population with high morbidity and mortality, an increased risk of hypoglycemic episodes and large intra- and interdialysis glyc
Externí odkaz:
https://doaj.org/article/3bd5708a236047a8b644407c058f7d67
Autor:
Anne Zanchi, Andreas W. Jehle, Faiza Lamine, Bruno Vogt, Cecilia Czerlau, Stefan Bilz, Harald Seeger, Sophie de Seigneux
Publikováno v:
Swiss Medical Weekly, Vol 153, Iss 1 (2023)
Diabetic kidney disease is highly prevalent in patients with type 2 diabetes and is a major cause of end-stage renal disease in Switzerland. Patients with diabetic kidney disease are among the most complex patients in diabetes care. They require a mu
Externí odkaz:
https://doaj.org/article/1db420874827427dacc5598bf2b4fc60
Autor:
Anne Zanchi, Menno Pruijm, Marie-Eve Muller, Arlène Ghajarzadeh-Wurzner, Marc Maillard, Nathalie Dufour, Olivier Bonny, Grégoire Wuerzner, Michel Burnier
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundSodium–glucose co-transport 2 inhibitors (SGLT2i) lower blood pressure (BP) in normotensive subjects and in hypertensive and normotensive diabetic and non-diabetic patients. However, the mechanisms of these BP changes are not fully unders
Externí odkaz:
https://doaj.org/article/09e8e7bc634444ffb8937ad633e142ae
Autor:
Gilbert Greub, Isabella Locatelli, Aurélie Augsburger, Priska Birrer, Joelle Schwarz, Anne Zanchi, Isabelle Jacot-Sadowski, Jardena J Puder
Publikováno v:
BMJ Open, Vol 10, Iss 11 (2020)
Introduction Few studies have assessed the efficacy of smoking cessation interventions in individuals with type 2 diabetes, but interventions adapted to the specific needs of this population are warranted. The aim of this study is to assess the effic
Externí odkaz:
https://doaj.org/article/e3743b12e9cc4cbe9bc8ebdb05acd709
Autor:
Anne Zanchi, Michel Burnier, Marie‐Eve Muller, Arlène Ghajarzadeh‐Wurzner, Marc Maillard, Nicolas Loncle, Bastien Milani, Nathalie Dufour, Olivier Bonny, Menno Pruijm
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 13 (2020)
Background The sodium/glucose cotransporter 2 inhibitor empagliflozin has cardiorenal protective properties through mechanisms beyond glucose control. In this study we assessed whether empagliflozin modifies renal oxygenation as a possible mechanism
Externí odkaz:
https://doaj.org/article/59f69b1c06214c859127f567b5bff796